Methods
insufficiency of the future liver remnant, hepatocellular carcinoma
HEPATOCELLULAR CARCINOMA
The RALLY study is a multicenter, interventional, non-randomized, open-label, non-comparative safety study. Patients with hepatocellular carcinoma who are considered ineligible for surgery due to insufficiency of the future liver remnant (< 2.7%/min/m